Carcinoma broncogénico en pacientes con infección por virus de la inmunodeficiencia humana

Translated title of the contribution: Bronchogenic carcinoma in patients with human immunodeficiency virus infection

Oriol Estrada, Joan Romeu, Georgina Giménez, Antoni Raventós, Guillem Sirera, Bonaventura Clotet

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


The diagnosis of bronchogenic carcinoma (BC) in patients with HIV infection is infrequent. Five cases are described and the existing references reviewed. The incidence, risk factors, clinical manifestations, histology, age of onset, diagnosis and survival in HIV positive patients with BC were analyzed. The clinical histories of 2,586 patients with HIV infection seen in the authors' center were reviewed. Five cases in whom BC was detected were found. Sixty-nine cases published in the international literature were collected in a reference search by the MEDLINE system between 1982-1994. The patients with BC and HIV infection have an early age of presentation (mean age: 42 years) and a lower survival with respect to those without infection. No differences were observed with regard to the smoking habit, procedures for achieving diagnosis or clinical manifestations. The predominant histologic subtype was adenocarcinoma. A higher incidence of BC was observed in patients with HIV infection with respect to the control groups on elimination of the bias for age and risk factors for BC. Given its low incidence, BC should be considered in the differential diagnosis of pulmonary disease in patients with HIV infection in cases presenting a history of smoking, once the most common opportunistic infections have been discarded.

Translated title of the contributionBronchogenic carcinoma in patients with human immunodeficiency virus infection
Original languageSpanish
Pages (from-to)661-664
Number of pages4
JournalMedicina Clinica
Issue number17
StatePublished - 1996
Externally publishedYes


Dive into the research topics of 'Bronchogenic carcinoma in patients with human immunodeficiency virus infection'. Together they form a unique fingerprint.

Cite this